Is it possible to deliver pulmonary rehabilitation in a community setting to people in Sri Lanka living with chronic obstructive lung disease?

Assess the feasibility and acceptability of a community based pulmonary rehabilitation programme incorporating dancing for people with COPD in Colombo district in Sri Lanka: Global RECHARGE Sri Lanka

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN10521920

Enrollment

Registered

2019-09-12

Start date

2020-09-01

Completion date

Unknown

Last updated

2022-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease Respiratory

Interventions

A feasibility RCT of Pulmonary Rehabilitation versus usual care (control). Participants will be individually randomised (1:1) to the Pulmonary Rehabilitation programme or to the control group (usual c

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stage 1 (patient): 1. Aged =18 years 2. Physician diagnosis of COPD Stage 1 (staff): 1. Healthcare staff that would typically refer patients to a clinical Pulmonary Rehabilitation programme, such as physicians & clinicians. Stage 2: 1. Aged =18 years 2. Physician diagnosis of COPD 3. Spirometry confirmed COPD, based on GOLD criteria, with FEV1/FVC <0.7, and FEV1<80% predicted 4. Medical Research Council (MRC) dyspnoea score grade 2 or higher

Exclusion criteria

Exclusion criteria: 1. Comorbidities such as severe or unstable cardiovascular, other internal diseases and locomotor difficulties that preclude exercise 2. Malignant disease or other serious illness which will interfere with participation in the Pulmonary Rehabilitation programme 3. Unable or unwilling to provide informed consent

Design outcomes

Primary

Measure	Time frame
Feasibility measures including: 1. Suitability of the inclusion criteria 2. Refusal rate 3. Uptake and completion of the study 4. Willingness of patients to be recruited and the willingness of healthcare professionals to refer to this study and future trials 5. Service provider and multi-disciplinary teams’ willingness and ability to deliver the new PR programme 6. The practicality of delivering the intervention in the proposed setting 7. The time needed to collect and analyse the data 8. Test methods for the collection of data as well as data completeness and accuracy 9. The acceptability of the PR programme, assessed through focus groups 10. Compliance to the PR sessions 11. Adherence to home exercise assessed via a self-report exercise diary 12. The training and resource needed to deliver the intervention (ensuring readiness for a future multi-centre trial)	—

Measure

Time frame

Feasibility measures including: 1. Suitability of the inclusion criteria 2. Refusal rate 3. Uptake and completion of the study 4. Willingness of patients to be recruited and the willingness of healthcare professionals to refer to this study and future trials 5. Service provider and multi-disciplinary teams’ willingness and ability to deliver the new PR programme 6. The practicality of delivering the intervention in the proposed setting 7. The time needed to collect and analyse the data 8. Test methods for the collection of data as well as data completeness and accuracy 9. The acceptability of the PR programme, assessed through focus groups 10. Compliance to the PR sessions 11. Adherence to home exercise assessed via a self-report exercise diary 12. The training and resource needed to deliver the intervention (ensuring readiness for a future multi-centre trial)

—

Secondary

Measure	Time frame
Measured at baseline and 6 weeks post baseline: 1. Anxiety and depression level, measured using Hospital Anxiety and Depression Scale (HADS) 2. Breathlessness, measured using Medical Research Council (MRC) Dyspnea scale 3. Health status, measured using COPD Assessment Test (CAT) and Clinical COPD Questionnaire (CCQ) 4. Economic impact, measured using Work Productivity and Activity impairment (WPAI) Questionnaire 5. Nutritional status, measured by body weight using scales, body composition using bioelectrical impedance and skinfold thickness, and 7-day diet diary 6. Lung health, assessed by spirometry, impulse oscillometry and diffusing capacity for carbon monoxide 7. Exercise capacity, measured by incremental shuttle walking test (ISWT) and the endurance shuttle walking test (ESWT) 8. Physical activity, measured by ActiGraph wGT3x-BT accelerometer 9. Physical function, measured by 5x sit-to-stand test	—

Measure

Time frame

Measured at baseline and 6 weeks post baseline: 1. Anxiety and depression level, measured using Hospital Anxiety and Depression Scale (HADS) 2. Breathlessness, measured using Medical Research Council (MRC) Dyspnea scale 3. Health status, measured using COPD Assessment Test (CAT) and Clinical COPD Questionnaire (CCQ) 4. Economic impact, measured using Work Productivity and Activity impairment (WPAI) Questionnaire 5. Nutritional status, measured by body weight using scales, body composition using bioelectrical impedance and skinfold thickness, and 7-day diet diary 6. Lung health, assessed by spirometry, impulse oscillometry and diffusing capacity for carbon monoxide 7. Exercise capacity, measured by incremental shuttle walking test (ISWT) and the endurance shuttle walking test (ESWT) 8. Physical activity, measured by ActiGraph wGT3x-BT accelerometer 9. Physical function, measured by 5x sit-to-stand test

—

Countries

Sri Lanka, United Kingdom

Contacts

Public ContactMark Orme

mwo4@leicester.ac.uk+44 (0)1162583113

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026